Karyopharm Therapeutics Inc.

Karyopharm Therapeutics is a commercial-stage pharmaceutical company pioneering novel first-in-class cancer therapies and dedicated to the discovery, development, and commercialization of drugs to treat cancer. We are recognized leaders in XPO1 inhibition. We believe in the extraordinary – in the dedication to positively impact patient lives and treat cancer.